---

Highlights for November 2016

1. Sun Pharma to acquire 85.1% of JSC Biosintez in Russia
2. UK subsidiary of Strides to acquire PediaCare from Moberg Pharma for USD 5 million
3. Micro Labs is close to acquiring a Hyderabad drug maker marking its first known inorganic expansion move
4. Aurobindo Pharma may buy Portugal's Generis, deal likely to be valued at USD 200 million
5. Karo Pharma AB paid SEK908mm ($101mm) in cash to buy Medivir AB's commercial products division BioPhausia AB
6. Celldex buys Kolltan for $62.5mm, plus earn-outs, in stock-for-stock deal
7. Eagle Pharmaceuticals Inc. acquired private biotech company Arsia Therapeutics Inc. for total consideration of up to $78mm
8. Sorrento's TNK acquires Virttu Biologics
9. OncBioMune Broadens Portfolio, Partners and Product with Vitel Acquisition